Observational study on the evolution of systemic treatments for advanced renal cell carcinoma in Southwest Finland between 2010 and 2021

BACKGROUND: Novel receptor tyrosine kinase inhibitors and immune checkpoint inhibitors have been introduced to the treatment of advanced renal cell carcinoma (aRCC) during the past decade. However, the adoption of novel treatments into clinical practice has been unknown in Finland. OBJECTIVES: Our a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hölsä, Olivia, Teittinen, Kaisa, Anttalainen, Anna, Ukkola-Vuoti, Liisa, Summanen, Milla, Mattila, Kalle E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Future Perspectives in Renal Cell Carcinoma: The Promise of Advanced Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629305/
https://www.ncbi.nlm.nih.gov/pubmed/37941979
http://dx.doi.org/10.1177/17562872231206243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629305/
https://www.ncbi.nlm.nih.gov/pubmed/37941979
http://dx.doi.org/10.1177/17562872231206243

Ejemplares similares